InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.74
(
0.69%
)
US TECH 100
20,084.00
(
0.87%
)
Dow Jones
39,498.92
(
0.53%
)
Brent Oil
84.77
(
0.08%
)
Bitcoin
57,599.02
(
-0.72%
)

Replies to post #21019 on Radient Pharmaceuticals Corporation fka RXPC

Replies to #21019 on Radient Pharmaceuticals Corporation fka RXPC

dcspka

04/21/14 9:57 PM

#21020 RE: dcspka #21019

The cross synergies between Provista/GCDX/Memory DX/RXPC Takeover and licensing arrangements with SRL, Uni-Pharma, Amarantus, etc will be very lucrative for all with Insighter perception.